Does TADALAFIL Cause Infusion site induration? 17 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Infusion site induration have been filed in association with TADALAFIL (Esokalli Testosterone Booster Oral Dissolving Film). This represents 0.1% of all adverse event reports for TADALAFIL.
17
Reports of Infusion site induration with TADALAFIL
0.1%
of all TADALAFIL reports
0
Deaths
6
Hospitalizations
How Dangerous Is Infusion site induration From TADALAFIL?
Of the 17 reports, 6 (35.3%) required hospitalization.
Is Infusion site induration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TADALAFIL. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does TADALAFIL Cause?
Headache (3,196)
Drug ineffective (2,943)
Dyspnoea (2,881)
Death (1,917)
Diarrhoea (1,667)
Dizziness (1,374)
Nausea (1,368)
Asthenia (1,230)
Fatigue (1,135)
Hypertension (1,044)
What Other Drugs Cause Infusion site induration?
TREPROSTINIL (598)
HUMAN IMMUNOGLOBULIN G (209)
FOSCARBIDOPA\FOSLEVODOPA (112)
AMBRISENTAN (49)
MACITENTAN (26)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (25)
CAPECITABINE (23)
EVEROLIMUS (22)
ZOLEDRONIC ACID (22)
PAMIDRONATE (20)
Which TADALAFIL Alternatives Have Lower Infusion site induration Risk?
TADALAFIL vs TAFAMIDIS
TADALAFIL vs TAFAMIDIS MEGLUMINE
TADALAFIL vs TAFASITAMAB
TADALAFIL vs TAFASITAMAB-CXIX
TADALAFIL vs TAFINLAR